|
09/07/2021 |
CIGB-Mambisa/Abdala in convalescents |
CIGB |
Registered outdated |
|
01/07/2021 |
Evaluation of the safety and immunogenicity of the vaccine candidate "ABDALA" in children and adolescents |
CIGB |
Registered |
|
03/09/2021 |
MEÑIQUE Study |
CIGB |
Registered |
|
20/04/2022 |
Jusvinza in rheumatoid arthritis |
CIGB |
Registered |
|
06/12/2022 |
Nasal recombinant human interferon alfa-2b in ARI |
CIGB |
Registered |
|
29/07/2022 |
Nasalferon in ARI |
CIGB |
Registered |
|
06/07/2023 |
Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shock |
CIGB |
Registered |
|
24/04/2023 |
Efficacy and safety of Jusvinza treatment in patients with acute respiratory distress syndrome. Phase II/III |
CIGB |
Registered |
|
27/02/2024 |
Jusvinza in adult patients with Rheumatoid Arthritis from Camaguey and Eastern Provinces |
CIGB_IB |
Registered |
|
2012-07-20 |
T1h in severe psoriasis-expanded access program (PUCE) |
CIM |
Registered |
|
2010-12-03 |
1E10 anti-idiotype vaccine, metastatic colon, phase II. |
CIM |
Registered |
|
2010-12-24 |
Toxicological evaluation of the humanized Anti-CD6 MAb T1h in Rheumatoid Arthritis Patients |
CIM |
Registered |
|
2010-12-27 |
1E10 anti-idiotype vaccine, metastatic breast cancer, phase II |
CIM |
Registered |
|
2010-12-28 |
Anti-idiotype 1E10 vaccine in advanced non- small cell lung (NSCLC) patients |
CIM |
Registered |
|
2010-12-28 |
Anti-idiotype 1E10 vaccine in the treatment of patients with small cell lung (SCLC) patients |
CIM |
Registered |
|
2010-12-28 |
h-R3 MaB and radiotherapy in pediatric patients with intrinsic diffuse astrocytomas of brain stem, phase II. |
CIM |
Registered |
|
2010-12-28 |
hR3 MaB and radiotherapy in highly malignant astrocytic tumors, phase III. |
CIM |
Registered |
|
2010-12-29 |
h-R3 MAb combined with radio chemotherapy to treat non-surgical esophagus tumors of epithelial origin. |
CIM |
Registered |
|
2010-12-29 |
NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II. |
CIM |
Registered |
|
2010-12-29 |
Patients with non small cells lung cancer (NSCLC) and brain metastasis. |
CIM |
Registered |
